1644545-52-7 vorasidenib
Non pwodwi: vorasidenib
CAS: 1644545-52-7
MF: C14H13CLF6N6
MW: 414.74
Einecs:
MDL No.:MFCD31630835
Pwopriyete
Aparans limyè jòn nan limyè mawon cristalline poud
Pwen bouyi: 467.5 ± 55. 0 degre
Dansite 1.491 ± 0. 06 g\/cm3
Depo tanperati. Magazen nan -20 degre
Aplikasyon:
Vorasidenib (non komès Voranigo) se yon oral, nan sèvo penetrasyon doub inibitè nan IDH1 ak IDH2, prensipalman itilize pou tretman nan IDH mutan gliom difize.
Sinonim:
Vorasidenib
1644545-52-7
Ag -881
Voranigo
1,3, 5- triazine -2, 4- Diamine, 6- (6- chloro -2- piridinil) -n2, n 4- bis [(1r) -2, 2, 2- trife
vorasidenibum
6- (6- chloro -2- piridinil) -n, n'-bis ((2r) -1, 1, 1- Tri fluoro -2- propanyl) -1, 3, 5- triazine -2, 4- Diamine
Baj popilè: 1644545-52-7 vorasidenib, Lachin 1644545-52-7 manifaktirè vorasidenib, founisè
